CD4 and neoplasm: Globally, we detected 266 CD4+CD8+ double positive T cells out of 12,039 total cells (2.2%) analyzed with whole transcriptome scRNAseq platform, and 221 (83%) of them were from tumor, representing 4.5% of the 4,844 tumor-derived T cells.